Loading stock data…
Bio-Techne Corporation (TECH)
$72.31-0.12 (-0.17%)
Market ClosedLast close Sep 8
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Bio-Techne Corporation in the Healthcare sector is trading at $72.31 with a market capitalization of $8.8B. Wall Street consensus targets $70.73 (11 analysts), implying a -2.2% move over the next 12 months. The stock is currently near its 52-week high of $72.62, remaining 18.7% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $311.42M↑ | $295.88M↑ | $286.56M↓ | $316.96M↑ | $316.18M |
| Gross Profit | $208.29M↑ | $191.28M↑ | $188.11M↓ | $198.81M↓ | $214.56M |
| Operating Income | $75.50M↑ | $54.46M↑ | $47.66M↓ | $116.69M↑ | $38.71M |
| Net Income | $51.05M↑ | $38.01M↓ | $38.19M↑ | -$17.68M↓ | $22.59M |
Peer Comparison
JNJUNHPFE
Fundamentals
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.76B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.33%
ROE
Average efficiency. Growth may require heavy reinvestment.
5.25%
Volume
Today's trading volume
2.06M
Recent News
Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bio-Techne (NASDAQ:TECH) and its peers.
1 Surging Stock for Long-Term Investors and 2 That Underwhelm
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
1 Profitable Stock to Own for Decades and 2 We Turn Down
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Is Wall Street Bullish or Bearish on Bio-Techne Stock?
Bio-Techne has outperformed the broader market over the past year, but analysts are cautious about the stock’s prospects.
3 High-Flying Stocks We Approach with Caution
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.